CESAR Fax (1992 to 2015)CESAR FAX provided a weekly, one-page overview of timely substance abuse trends or issues to more than 6,000 subscribers via email each Monday morning. Recipients included Federal and State policymakers; prevention specialists; treatment and health care providers; law enforcement officials; researchers and academicians; and media representatives. By default, all available issues are displayed below, but you may select one option each from year, topic, drug and population to narrow your search. |
|
Date | Volume/Issue | Title |
July 11, 2011 | Volume 20, Issue 26 | 61% of Buprenorphine-Related Emergency Department Visits for Nonmedical Use |
July 5, 2011 | Volume 20, Issue 25 | Number of U.S. Emergency Department Visits Related to the Nonmedical Use of Buprenorphine More Than Triples Since 2006 |
June 27, 2011 | Volume 20, Issue 24 | Number of Law Enforcement-Seized Buprenorphine Items Analyzed by U.S. Labs Increases Dramatically |
June 20, 2011 | Volume 20, Issue 23 | U.S. Retail Distribution of Burprenorphine Approaches 1.5 Million Grams |
June 13, 2011 | Volume 20, Issue 22 | Buprenorphine Treatment for Opioid Dependence |
June 6, 2011 | Volume 20, Issue 21 | Increases in Unintentional Overdose Deaths Involving Opioid Analgesics Mirror Rise in Per Capita Sales of These Drugs |
May 31, 2011 | Volume 20, Issue 20 | Number of Unintentional Opioid Analgesic Overdose Deaths Increases Fourfold Since 1999; Responsible for More Than Cocaine and Heroin Combined |
May 23, 2011 | Volume 20, Issue 19 | Unintentional Drug Overdose Deaths Continue to Increase; Now Second Leading Cause of Unintentional Deaths |
May 16, 2011 | Volume 20, Issue 18 | Majority of U.S. Ecstasy-Related Emergency Department Visits Also Involve Other Drugs |
May 9, 2011 | Volume 20, Issue 17 | DEA Temporarily Classifies Synthetic Marijuana as a Schedule I Drug |